相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Use of Rituximab for persistent EBV DNAemia, and Its effect on donor-specific antibody development in pediatric renal transplant recipients: A case series
Dechu P. Puliyanda et al.
PEDIATRIC TRANSPLANTATION (2021)
EBV-miR-BHRF1 Targets p53 Gene: Potential Role in Epstein-Barr Virus Associated Chronic Lymphocytic Leukemia
Dan-Min Xu et al.
CANCER RESEARCH AND TREATMENT (2020)
miRNAs: EBV Mechanism for Escaping Host's Immune Response and Supporting Tumorigenesis
Snjezana Zidovec Lepej et al.
PATHOGENS (2020)
EBV miRNA expression profiles in different infection stages: A prospective cohort study
Anita Hartung et al.
PLOS ONE (2019)
Systemic and Intra-Nodal Activation of NK Cells After Rituximab Monotherapy for Follicular Lymphoma
Monika Enqvist et al.
FRONTIERS IN IMMUNOLOGY (2019)
Plasma EBV microRNAs in paediatric renal transplant recipients
Jaythoon Hassan et al.
JOURNAL OF NEPHROLOGY (2018)
Evaluation of circulating EBV microRNA BART2-5p in facilitating early detection and screening of nasopharyngeal carcinoma
Chen Jiang et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Dissecting the regulation of EBV's BART miRNAs in carcinomas
Ya-Chun Yang et al.
VIROLOGY (2017)
Dynamic expression of viral and cellular microRNAs in infectious mononucleosis caused by primary Epstein-Barr virus infection in children
Liwei Gao et al.
VIROLOGY JOURNAL (2015)
Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment
Gaohong Zhang et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
EBV-Encoded miR-BART20-5p and miR-BART8 Inhibit the IFN-γ-STAT1 Pathway Associated with Disease Progression in Nasal NK-Cell Lymphoma
Wei-Ting Huang et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Adapted Treatment of Epstein-Barr Virus Infection to Prevent Posttransplant Lymphoproliferative Disorder After Heart Transplantation
S. Choquet et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
Profiling Plasma MicroRNA in Nasopharyngeal Carcinoma with Deep Sequencing
Hai-Yun Wang et al.
CLINICAL CHEMISTRY (2014)
Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients
R. San-Juan et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients
Arumugam Palanichamy et al.
JOURNAL OF IMMUNOLOGY (2014)
Plasma Viral MicroRNA Profiles Reveal Potential Biomarkers for Chronic Active Epstein-Barr Virus Infection
Yoshihiko Kawano et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Comprehensive profiling of Epstein-Barr virus-encoded miRNA species associated with specific latency types in tumor cells
Hong-Jie Yang et al.
VIROLOGY JOURNAL (2013)
T-bet: a bridge between innate and adaptive immunity
Vanja Lazarevic et al.
NATURE REVIEWS IMMUNOLOGY (2013)
EBV encoded miR-BHRF1-1 potentiates viral lytic replication by downregulating host p53 in nasopharyngeal carcinoma
Zijian Li et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
EBV-encoded miRNAs
Stephanie Barth et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2011)
Quantitative Studies of Epstein-Barr Virus-Encoded MicroRNAs Provide Novel Insights into Their Regulation
Richard Amoroso et al.
JOURNAL OF VIROLOGY (2011)
The Members of an Epstein-Barr Virus MicroRNA Cluster Cooperate To Transform B Lymphocytes
Regina Feederle et al.
JOURNAL OF VIROLOGY (2011)
Incidence and Predictive Factors for Infectious Disease after Rituximab Therapy in Kidney-Transplant Patients
N. Kamar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Functional delivery of viral miRNAs via exosomes
D. Michiel Pegtel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The microRNAs of Epstein-Barr Virus are expressed at dramatically differing levels among cell lines
Zachary L. Pratt et al.
VIROLOGY (2009)
The Role of Complement in the Mechanism of Action of Rituximab for B-Cell Lymphoma: Implications for Therapy
Xuhui Zhou et al.
ONCOLOGIST (2008)
Identification of virus-encoded microRNAs
S Pfeffer et al.
SCIENCE (2004)
Rituximab as treatment for refractory kidney transplant rejection
YT Becker et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)